Quality of life in lung cancer survivors treated with tyrosine-kinase inhibitors (TKI): results from the multi-centre cross-sectional German study LARIS

PURPOSE: We aimed at exploring the quality of life (QOL) of lung cancer survivors with proven tyrosine-kinase receptor (RTK) genetic alterations and targeted tyrosine-kinase inhibitors (TKI) therapy, compared to lung cancer survivors with no-RTK alterations and no-TKI therapy. METHODS: Data were col...

Descripción completa

Detalles Bibliográficos
Autores principales: Riccetti, Nicola, Blettner, Maria, Taylor, Katherine, Wehler, Beatrice, Gohrbandt, Bernhard, Nestle, Ursula, Bals, Robert, Stockinger, Marcus, Wehler, Thomas, Singer, Susanne, Eichler, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article – Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293811/
https://www.ncbi.nlm.nih.gov/pubmed/35608689
http://dx.doi.org/10.1007/s00432-022-03975-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293811/
https://www.ncbi.nlm.nih.gov/pubmed/35608689
http://dx.doi.org/10.1007/s00432-022-03975-6

Ejemplares similares